Literature DB >> 28739489

Colonoscopy and sigmoidoscopy use among older adults in different countries: A systematic review.

Chen Chen1, Eileen Läcke1, Christian Stock2, Michael Hoffmeister1, Hermann Brenner3.   

Abstract

Screening for colorectal cancer (CRC) by colonoscopy and sigmoidoscopy has been demonstrated to be effective in reducing CRC incidence and mortality, and they are increasingly employed as screening tests and for diagnostic purposes in many countries. We conducted a systematic review to provide up-to-date estimates on the utilization of lower gastrointestinal endoscopy (colonoscopy and sigmoidoscopy) in the general average-risk population in different countries. PubMed and Web of Science were searched for relevant articles published between 1 September 2008 and 31 October 2016. A total of 23 studies from the US and 20 studies from other countries were included in this review. Estimates from the US were highest, continued to increase over the past decade and reached 62% for colonoscopy use within 10years in people aged 50-75years in 2012. Endoscopy use in other countries was substantially lower (12-44% for lifetime colonoscopy use and 13-30% for recent colonoscopy use), except for Germany, where 55% of the screening-eligible population reported colonoscopy utilization within the previous 10years in 2008-2011. Both lifetime and recent endoscopy use increased with age and peaked at approximately 70-75years. Although several European and Asian countries have started to collect endoscopy utilization data through periodic national health surveys, more data are still much needed from non-US countries. With the implementation of CRC screening programs in an increasing number of countries, especially European countries, an increase in endoscopy use and subsequent reduction in CRC incidence and mortality in the years to come might be expected in those countries.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colonoscopy; Mass screening; Sigmoidoscopy; Systematic review; Utilization

Mesh:

Year:  2017        PMID: 28739489     DOI: 10.1016/j.ypmed.2017.07.021

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

1.  Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland.

Authors:  Alexander Leonhard Braun; Emanuele Prati; Yonas Martin; Charles Dvořák; Kali Tal; Nikola Biller-Andorno; Jean-Luc Bulliard; Jacques Cornuz; Kevin Selby; Reto Auer
Journal:  Int J Public Health       Date:  2019-06-15       Impact factor: 3.380

2.  Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer.

Authors:  Sherri Sheinfeld Gorin
Journal:  Ann Fam Med       Date:  2019-09       Impact factor: 5.166

3.  Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012.

Authors:  Alexander Leonhard Braun; Anja Kässner; Lamprini Syrogiannouli; Kevin Selby; Jean-Luc Bulliard; Yonas Martin; Idris Guessous; Kali Tal; Cinzia Del Giovane; Marcel Zwahlen; Reto Auer
Journal:  Prev Med Rep       Date:  2020-05-04

Review 4.  Circulating tumor cells in colorectal cancer in the era of precision medicine.

Authors:  Mingchao Hu; Zhili Wang; Zeen Wu; Pi Ding; Renjun Pei; Qiang Wang; Chungen Xing
Journal:  J Mol Med (Berl)       Date:  2021-11-20       Impact factor: 4.599

5.  Utilisation of outpatient medical services in Germany - Results from GEDA 2019/2020-EHIS.

Authors:  Franziska Prütz; Alexander Rommel; Julia Thom; Yong Du; Giselle Sarganas; Anne Starker
Journal:  J Health Monit       Date:  2021-09-15

6.  DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.

Authors:  Mingchao Hu; Jianchun Gu; Wenzhao Su; Zhenjie Zhang; Baosong Zhu; Qiang Wang; Chungen Xing
Journal:  Biomed Res Int       Date:  2021-11-30       Impact factor: 3.411

Review 7.  The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention.

Authors:  Hermann Brenner; Chen Chen
Journal:  Br J Cancer       Date:  2018-10-04       Impact factor: 7.640

Review 8.  Choosing wisely in oncology: necessity and obstacles.

Authors:  Piercarlo Saletti; Piero Sanna; Luca Gabutti; Michele Ghielmini
Journal:  ESMO Open       Date:  2018-07-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.